CRIZOTINIB

12739 reported adverse events

Drug classes: Kinase Inhibitor [EPC]

These side effects are most commonly reported by patients taking CRIZOTINIB:

# Side effect Count
0 DEATH 2379
1 DISEASE PROGRESSION 1217
2 NAUSEA 1124
3 NEOPLASM PROGRESSION 1110
4 DIARRHOEA 849
5 VOMITING 799
6 FATIGUE 557
7 OFF LABEL USE 474
8 OEDEMA PERIPHERAL 449
9 CONSTIPATION 442
See all common reactions for CRIZOTINIB

CRIZOTINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NON-SMALL CELL LUNG CANCER STAGE IV 25 0.0685
1 LUNG ADENOCARCINOMA STAGE IV 25 0.0656
2 NON-SMALL CELL LUNG CANCER 287 0.0599
3 NON-SMALL CELL LUNG CANCER METASTATIC 52 0.0592
4 RENAL ABSCESS 46 0.0562
5 NEOPLASM PROGRESSION 1110 0.0319
6 ACQUIRED GENE MUTATION 40 0.0305
7 LUNG ADENOCARCINOMA 87 0.0289
8 PHOTOPSIA 135 0.0213
9 PLEURAL THICKENING 14 0.0205
See all enriched reactions for CRIZOTINIB